...We Welcome You To The Resverlogix HUB In The AGORACOM COMMUNITY!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** Trial is Fully Enrolled and Top-Line Results Expected Q1 2019

Free
Message: Resverlogix Repays $68.8 Million Loan

Is a perfect storm brewing?  One that is good not just for a short term boost but for longer term appreciation of the PPS? 

We've got news, and by the look of things increased exposure....we have 170 odd thousand shares that have been borrowed and dumped back into the market, and if the PPS starts jumping they'll need to be covered....that's 2 or 3 days worth of volume right there.

Looks like the next tick in the box could be the FA....

 

Share
New Message
Please login to post a reply